|
medpundit |
||
 |
 |
|
Friday, September 05, 2003The Middle Atlantic region will receive a five-year, $42 million grant from the National Institute of Allergy and Infectious Diseases. Besides creating vaccines to guard against anthrax, smallpox and West Nile virus, they will study antibodies that could produce short-term protection. I didn't think anyone outside one or two senators really thought West Nile virus was the work of terrorists. But here's what they really plan to work on: The regional researchers will study viruses that cause hemorrhage fever, such as ebola and Marburg, and target E. coli and shigella, bacteria considered to be threats because a small amount causes severe illness. Researches will also design better diagnostic tests and needle-free vaccinations for fast response to a biological attack or infectious disease outbreak. posted by Sydney on 9/05/2003 08:53:00 AM 0 comments 0 Comments: |
|
